Show
Sort by
-
- Journal Article
- A1
- open access
Molecular imaging of tumor-associated angiogenesis using a novel magnetic resonance imaging contrast agent targeting αvβ3 integrin
-
Pharmacologic activation of tumor hypoxia: a means to increase tumor 2-deoxy-2-[18F]fluoro-D-glucose uptake?
-
Cisplatin-modified de Gramont in second-line therapy for pancreatic adenocarcinoma
-
Standardized added metabolic activity (SAM) IN 18F-FDG PET assessment of treatment response in colorectal liver metastases
-
- Journal Article
- A1
- open access
Clinical procedure for colon carcinoma tissue sampling directly affects the cancer marker-capacity of VEGF family members
-
Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases
-
99mTc-labeled tricarbonyl His-CNA35 as an imaging agent for the detection of tumor vasculature
-
Antitumour efficacy of two paclitaxel formulations for hyperthermic intraperitoneal chemotherapy (HIPEC) in an in vivo rat model
-
- Conference Paper
- C3
- open access
FDG-PET is a predictor of metabolic response to chemotherapy in metastatic colorectal cancer (mCRC)
-
Postoperative outcome in patients with intraductal papillary mucinous neoplasia of the pancreas and pancreatic neuroendocriene tumors
-
- Conference Paper
- C3
- open access
Efficacy of the combined use of bevacizumab and irinotecan in a human colorectal cancer xenograft model analysed by SPECT imaging
-
- Conference Paper
- C3
- open access
PET as a predictor of metabolic response to antiangiogenic therapy in metastatic colorectal cancer (mCRC)
-
- Conference Paper
- C3
- open access
Preoperative chemotherapy for colorectal liver metastases : prediction of response by DCE-MRI abd FDG-PET/CT?
-
99mTc-(CO)3 His-annexin A5 micro-SPECT demonstrates increased cell death by irinotecan during the vascular normalization window caused by bevacizumab
-
Noninvasive monitoring of therapy-induced microvascular changes in a pancreatic cancer model using dynamic contrast-enhanced magnetic resonance imaging with P846, a new low-diffusible gadolinium-based contrast agent
-
Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights
-
An evaluation of FDG-PET as a predictor of metabolic response to chemotherapy in metastatic colorectal cancer patients (mCRC)
-
The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model
-
Assessment and prognostic vaule of regression after neoadjuvant therapy in rectal cancer: the role of tumor shrinkage and fragmentation
-
Diffusion magnetic resonance imaging as surrogate marker to anti-VEGF treatment response in MCTC
-
PET evaluation of anti-VEGF treatment in combination with chemotherapy in MCRC
-
Defining the optimal therapy sequence in synchronous respectable liver metastases from colorectal cancers: a decision analysis approach
-
Low molecular weight heparin inhibits tumor associated angiogenesis in vivo
-
Comparison of two contrast agents for DCE-MRI evaluation of anti-VEGF treatment in combination with chemotherapy in MCRC
-
Combined effect of EPO and radiotherapy on the expression of endogenous molecular markers of tumor metabolism and metastasis
-
Low molecular weight heparin inhibits tumor associated angiogenesis in vivo
-
MOLECULAR IMAGING OF TUMOR ASSOCIATED ANGIOGENESIS USING P1227, A NOVEL MRI CONTRAST AGENT TARGETING AVB3 INTEGRIN
-
Differential gene expression between metastatic colorectal tumours in liver and peritoneum.
-
Expression of SGLT1 and Bcl-2 in panreatic cancer and their metastases related to survival.
-
Molecular imaging of tumor associated angiogenesis using P1227, a noval MRI contrast agent targeting Alfa V Beta 3 integrin
-
Molecular imaging of tumor associated angiogenesis uzing P1127, a novel MRI contrast agent targeting alfa V beta 3 integrin
(2008) -
Expression of hexokinase II in pancreatic cancer predicts survival
-
Effects of the low molecular weight heparin nadroparin on tumour associated angiogenesis
-
Expression of SGLT1 and Bcl-2 in pancreatic cancer and their metastases related to survival
-
Advances in the management of gastrointestinal stromal tumours
-
Microsatellite instability in Belgian sporadic colon carcinomas has no independent prognostic value in a Belgian study population
-
Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival
-
Effects of the low molecular weight heparin nadroparin on tumor associated angiogenesis
-
Gene expression differentiates liver metastases from isolated peritoneal metastases in colorectal cancer
-
Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer
-
Recombinant human erythropoietin α modulates the effects of radiotherapy on colorectal cancer microvessels
-
Squamous cell carcinoma of the anus: a possible target for EGFR inhibition?
-
Is combined F-18-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography superior to Positron Emission Tomography or Computed Tomography alone for diagnosis, staging and restaging of pancreatic lesions ?
-
- Journal Article
- A1
- open access
Noninvasive monitoring of radiotherapy-induced microvascular changes using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in a colorectal tumor model
-
Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy (HART) in resectable distal rectal cancer
-
Ki-67 and von Willebrand factor: outcome predictors for oesophageal cancer
-
Neoadjuvant chemoradiation versus hyperfractionated accelerated radio-therapy (HART) in respectable dital rectal cancer
-
Are von Willebrand factor and Ki-67 outcome predictors for esophageal cancer?
-
Use of PET/CT in pancreatic lesions
-
Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy (HART) in resectable distal rectal cancer
-
Limited influences of chemotherapy on healthy and metastatic liver parenchyma
-
In vivo mapping of the effects of radiotherapy on neovascular permeability using dynamic contrast enhanced MRI
-
In vivo mapping of the effects of radiotherapy on neovascular permeability using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI)
-
Limited influences of chemotherapy on healthy and metastatic liver parenchyma from colorectal cancer
-
Limited influences of chemotherapy on healthy and metastatic liver parenchyma from colorectal cancer
-
Limited influences of chemotherapy on healthy and metastatic liver parenchyma from colorectal cancer
-
Influences of chemotherapy on healthy and metastatic liver parenchyma is limited